GeneDx Holdings (WGS) Change in Inventory (2020 - 2026)

GeneDx Holdings (WGS) has 7 years of Change in Inventory data on file, last reported at -$1.7 million in Q1 2026.

• Change in Inventory for Q1 2026 came in at -$1.7 million, down 183.12% year-over-year; the trailing twelve-month figure through Mar 2026 was -$285000.0 (down 116.38% YoY), and the FY2025 annual result was $3.4 million, up 32.92% from the prior year.
• Change in Inventory slipped to -$1.7 million in Q1 2026 per WGS's latest filing, from $3.4 million in the prior quarter.
• Over five years, Change in Inventory peaked at $3.4 million in Q4 2025 and troughed at -$7.6 million in Q4 2022.
• A 5-year average of $59235.3 and a median of -$293000.0 in 2023 frame the typical range for Change in Inventory.
• On a YoY basis, Change in Inventory climbed as much as 640.97% in 2025 and fell as far as 379.25% in 2025.
• A 5-year view of Change in Inventory shows it stood at -$7.6 million in 2022, then surged by 96.14% to -$293000.0 in 2023, then surged by 254.95% to $454000.0 in 2024, then soared by 640.97% to $3.4 million in 2025, then sank by 150.21% to -$1.7 million in 2026.
• Business Quant data shows WGS's Change in Inventory at -$1.7 million in Q1 2026, $3.4 million in Q4 2025, and -$1.3 million in Q3 2025.